Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD55 and anti-CA9 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
There are currently no customer reviews or questions for Human Anti-CD55 x Anti-CA9 Bispecific Antibody (IgG-IgG) (BSIG-H295). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS